Susan H Alexander Biogen Inc. (BIIB) insider trading activity

Susan H Alexander is EVP Chief Legal Officer of BIOGEN INC.. Currently has a direct ownership of 31,601 shares of BIIB, which is worth approximately $4.51 Million. The most recent transaction as insider was on Nov 05, 2024, when has been sold 20,082 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.6K

38.86% 3M change

31.17% 12M change

Total Value Held $4.51 Million

SUSAN H ALEXANDER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 05 2024	SELL Bona fide gift	-	20,082 Reduced 38.86%	31,601 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$533,897 $219.08 p/Share	2,437 Reduced 4.5%	51,683 Common Stock
Feb 16 2024	BUY Exercise of conversion of derivative security	-	5,037 Added 8.76%	52,464 Common Stock
Feb 09 2024	SELL Payment of exercise price or tax liability	$226,039 $240.98 p/Share	938 Reduced 1.88%	49,083 Common Stock
Feb 09 2024	BUY Exercise of conversion of derivative security	-	2,575 Added 4.9%	50,021 Common Stock
Feb 08 2024	SELL Payment of exercise price or tax liability	$157,396 $240.3 p/Share	655 Reduced 1.36%	47,446 Common Stock
Feb 08 2024	BUY Exercise of conversion of derivative security	-	2,190 Added 4.35%	48,101 Common Stock
Feb 17 2023	SELL Payment of exercise price or tax liability	$258,615 $278.38 p/Share	929 Reduced 1.98%	45,911 Common Stock
Feb 17 2023	BUY Exercise of conversion of derivative security	-	1,920 Added 3.94%	46,840 Common Stock
Feb 10 2023	SELL Payment of exercise price or tax liability	$1,203,032 $286.3 p/Share	4,202 Reduced 8.55%	44,920 Common Stock
Feb 10 2023	BUY Exercise of conversion of derivative security	-	4,023 Added 7.68%	48,358 Common Stock
Jan 25 2023	BUY Grant, award, or other acquisition	-	5,703 Added 11.23%	45,099 Common Stock
Oct 27 2022	SELL Open market or private sale	$1,552,832 $280.7 p/Share	5,532 Reduced 12.31%	39,396 Common Stock
Feb 18 2022	SELL Payment of exercise price or tax liability	$138,252 $209.79 p/Share	659 Reduced 1.45%	44,928 Common Stock
Feb 18 2022	BUY Exercise of conversion of derivative security	-	1,485 Added 3.15%	45,587 Common Stock
Feb 12 2022	SELL Payment of exercise price or tax liability	$441,197 $214.59 p/Share	2,056 Reduced 4.45%	44,102 Common Stock
Feb 12 2022	BUY Exercise of conversion of derivative security	-	2,280 Added 4.76%	45,646 Common Stock
Jan 19 2022	BUY Grant, award, or other acquisition	-	2,825 Added 6.05%	43,878 Common Stock
Aug 09 2021	SELL Bona fide gift	-	523 Reduced 1.26%	41,053 Common Stock
Feb 12 2021	SELL Payment of exercise price or tax liability	$1,083,205 $278.03 p/Share	3,896 Reduced 8.57%	41,576 Common Stock
Feb 12 2021	BUY Exercise of conversion of derivative security	-	4,355 Added 9.1%	43,509 Common Stock
Jan 27 2021	BUY Grant, award, or other acquisition	-	4,545 Added 9.95%	41,117 Common Stock

Also insider at

IVC

INVACARE CORP Healthcare

Director

SHA